Invesco’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-155,206
| Closed | -$15.8M | – | 3774 |
|
|
2025
Q4 | $15.8M | Sell |
155,206
-141,227
| -48% | -$11.3M | ﹤0.01% | 1589 |
|
|
2025
Q3 | $16.2M | Buy |
296,433
+9,669
| +3% | +$483K | ﹤0.01% | 1561 |
|
|
2025
Q2 | $15.2M | Sell |
286,764
-91,887
| -24% | -$4.67M | ﹤0.01% | 1558 |
|
|
2025
Q1 | $16.4M | Sell |
378,651
-1,032
| -0.3% | -$52.3K | ﹤0.01% | 1531 |
|
|
2024
Q4 | $21.3M | Buy |
379,683
+138,089
| +57% | +$8.59M | ﹤0.01% | 1452 |
|
|
2024
Q3 | $16.5M | Sell |
241,594
-1,871
| -0.8% | -$106K | ﹤0.01% | 1575 |
|
|
2024
Q2 | $10.3M | Sell |
243,465
-21,819
| -8% | -$1.2M | ﹤0.01% | 1773 |
|
|
2024
Q1 | $18.3M | Sell |
265,284
-1,926,292
| -88% | -$122M | ﹤0.01% | 1504 |
|
|
2023
Q4 | $162M | Buy |
2,191,576
+11,789
| +0.5% | +$773K | 0.04% | 606 |
|
|
2023
Q3 | $149M | Sell |
2,179,787
-813,055
| -27% | -$69M | 0.04% | 592 |
|
|
2023
Q2 | $281M | Buy |
2,992,842
+790,334
| +36% | +$61.7M | 0.07% | 366 |
|
|
2023
Q1 | $149M | Buy |
2,202,508
+186,498
| +9% | +$12M | 0.04% | 574 |
|
|
2022
Q4 | $99.8M | Buy |
2,016,010
+6,201
| +0.3% | +$253K | 0.03% | 710 |
|
|
2022
Q3 | $65.3M | Sell |
2,009,809
-7,864
| -0.4% | -$324K | 0.02% | 808 |
|
|
2022
Q2 | $79.5M | Buy |
2,017,673
+39,682
| +2% | +$2.12M | 0.02% | 765 |
|
|
2022
Q1 | $138M | Buy |
1,977,991
+31,061
| +2% | +$2.27M | 0.04% | 654 |
|
|
2021
Q4 | $152M | Sell |
1,946,930
-496
| -0% | -$43.8K | 0.04% | 623 |
|
|
2021
Q3 | $186M | Sell |
1,947,426
-88,575
| -4% | -$9.35M | 0.05% | 538 |
|
|
2021
Q2 | $253M | Sell |
2,036,001
-18,060
| -0.9% | -$2.16M | 0.06% | 409 |
|
|
2021
Q1 | $271M | Sell |
2,054,061
-241,845
| -11% | -$33.1M | 0.07% | 347 |
|
|
2020
Q4 | $304M | Sell |
2,295,906
-526,460
| -19% | -$63.7M | 0.09% | 275 |
|
|
2020
Q3 | $288M | Sell |
2,822,366
-4,123
| -0.1% | -$356K | 0.1% | 244 |
|
|
2020
Q2 | $246M | Buy |
2,826,489
+124
| +0% | +$9.91K | 0.09% | 267 |
|
|
2020
Q1 | $164M | Buy |
2,826,365
+9,827
| +0.3% | +$798K | 0.07% | 336 |
|
|
2019
Q4 | $260M | Sell |
2,816,538
-333,769
| -11% | -$29.3M | 0.08% | 307 |
|
|
2019
Q3 | $285M | Buy |
3,150,307
+7,281
| +0.2% | +$830K | 0.07% | 324 |
|
|
2019
Q2 | $371M | Buy |
3,143,026
+2,634,078
| +518% | +$265M | 0.1% | 244 |
|
|
2019
Q1 | $44.1M | Sell |
508,948
-37,021
| -7% | -$3.15M | 0.01% | 868 |
|
|
2018
Q4 | $34.5M | Sell |
545,969
-115,693
| -17% | -$7.94M | 0.01% | 913 |
|
|
2018
Q3 | $52.2M | Sell |
661,662
-402,123
| -38% | -$26.2M | 0.02% | 845 |
|
|
2018
Q2 | $63.6M | Buy |
1,063,785
+120,705
| +13% | +$6.5M | 0.02% | 737 |
|
|
2018
Q1 | $38M | Sell |
943,080
-196,009
| -17% | -$9.56M | 0.01% | 864 |
|
|
2017
Q4 | $59.8M | Buy |
1,139,089
+168,061
| +17% | +$8.97M | 0.02% | 691 |
|
|
2017
Q3 | $45.8M | Buy |
971,028
+48,862
| +5% | +$1.97M | 0.02% | 806 |
|
|
2017
Q2 | $32.6M | Buy |
922,166
+319,170
| +53% | +$9.85M | 0.01% | 973 |
|
|
2017
Q1 | $14.2M | Sell |
602,996
-250,302
| -29% | -$4.96M | ﹤0.01% | 1355 |
|
|
2016
Q4 | $11.4M | Buy |
853,298
+568,361
| +199% | +$9.18M | ﹤0.01% | 1452 |
|
|
2016
Q3 | $5.29M | Buy |
284,937
+257,943
| +956% | +$4.55M | ﹤0.01% | 1938 |
|
|
2016
Q2 | $331K | Sell |
26,994
-2,542
| -9% | -$19.1K | ﹤0.01% | 3386 |
|
|
2016
Q1 | $199K | Sell |
29,536
-469,692
| -94% | -$3M | ﹤0.01% | 3561 |
|
|
2015
Q4 | $4.61M | Sell |
499,228
-2,857,204
| -85% | -$26.6M | ﹤0.01% | 1961 |
|
|
2015
Q3 | $60.4M | Sell |
3,356,432
-210,000
| -6% | -$4.82M | 0.03% | 661 |
|
|
2015
Q2 | $106M | Sell |
3,566,432
-88,221
| -2% | -$2.22M | 0.04% | 493 |
|
|
2015
Q1 | $80.5M | Sell |
3,654,653
-226,509
| -6% | -$5.75M | 0.03% | 599 |
|
|
2014
Q4 | $106M | Sell |
3,881,162
-366,887
| -9% | -$8.93M | 0.04% | 496 |
|
|
2014
Q3 | $82.3M | Sell |
4,248,049
-200,242
| -5% | -$3.67M | 0.03% | 567 |
|
|
2014
Q2 | $75.8M | Buy |
4,448,291
+1,288,222
| +41% | +$17.7M | 0.03% | 619 |
|
|
2014
Q1 | $44.8M | Buy |
3,160,069
+1,974,060
| +166% | +$26.7M | 0.02% | 835 |
|
|
2013
Q4 | $13.9M | Sell |
1,186,009
-572,288
| -33% | -$6.57M | 0.01% | 1361 |
|
|
2013
Q3 | $20.7M | Buy |
1,758,297
+450,266
| +34% | +$5.78M | 0.01% | 1143 |
|
|
2013
Q2 | $18.2M | Buy |
+1,308,031
| New | +$14.2M | 0.01% | 1138 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Invesco's EXAS Position: Q1 2026 in Review
Invesco sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 155,206 shares — an estimated $15.8M sold.
Invesco first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $371M in Q2 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Invesco reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Invesco sold 155,206 Exact Sciences shares in Q1 2026, an estimated $15.8M.
- Invesco first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
- Invesco's Exact Sciences position peaked at $371M in Q2 2019.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.